EF
BSX icon

Empirical Finance’s Boston Scientific BSX Stock Holding History

Empirical Finance’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04M Sell
48,397
-52
-0.1% -$4.16K 0.14% 131
2025
Q4 		$4.62M Sell
48,449
-2,127
-4% -$209K 0.22% 89
2025
Q3 		$4.94M Buy
50,576
+517
+1% +$53.5K 0.24% 88
2025
Q2 		$5.38M Buy
50,059
+338
+0.7% +$34.2K 0.28% 70
2025
Q1 		$5.02M Buy
49,721
+701
+1% +$70.6K 0.3% 66
2024
Q4 		$4.38M Sell
49,020
-619
-1% -$54.5K 0.25% 77
2024
Q3 		$4.16M Buy
49,639
+1,254
+3% +$98.9K 0.24% 80
2024
Q2 		$3.73M Sell
48,385
-2,895
-6% -$212K 0.23% 86
2024
Q1 		$3.51M Buy
51,280
+1,786
+4% +$115K 0.22% 103
2023
Q4 		$2.86M Buy
49,494
+401
+0.8% +$21.4K 0.2% 106
2023
Q3 		$2.59M Buy
49,093
+4,665
+11% +$245K 0.19% 109
2023
Q2 		$2.4M Buy
44,428
+4,843
+12% +$253K 0.19% 108
2023
Q1 		$1.98M Buy
39,585
+2,136
+6% +$101K 0.19% 114
2022
Q4 		$1.73M Buy
37,449
+2,989
+9% +$129K 0.18% 123
2022
Q3 		$1.33M Buy
34,460
+5,706
+20% +$229K 0.16% 130
2022
Q2 		$1.07M Buy
28,754
+1,536
+6% +$62.5K 0.14% 142
2022
Q1 		$1.21M Buy
27,218
+2,963
+12% +$128K 0.14% 136
2021
Q4 		$1.03M Buy
24,255
+6,527
+37% +$274K 0.12% 145
2021
Q3 		$769K Buy
17,728
+1,027
+6% +$45.4K 0.12% 178
2021
Q2 		$714K Buy
16,701
+2,206
+15% +$92.8K 0.12% 201
2021
Q1 		$521K Hold
14,495
– – 0.09% 197
2020
Q4 		$521K Buy
14,495
+2,564
+21% +$92.4K 0.09% 197
2020
Q3 		$456K Buy
11,931
+2,770
+30% +$107K 0.1% 184
2020
Q2 		$322K Buy
9,161
+1,145
+14% +$41.2K 0.08% 193
2020
Q1 		$262K Buy
8,016
+2,887
+56% +$113K 0.08% 173
2019
Q4 		$232K Buy
+5,129
New +$215K 0.06% 189
2017
Q1 		– Sell
-583
Closed -$13K – 155
2016
Q4 		$13K Buy
+583
New +$12.7K 0.01% 309

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empirical Finance's BSX Position: Q1 2026 in Review

Empirical Finance reduced its Boston Scientific (BSX) stake by 0.11% in Q1 2026, selling an estimated $4.16K and leaving 48,397 shares worth $3.04M. The position accounts for 0.14% of the portfolio, ranked #131.

Empirical Finance first reported a position in BSX in Q4 2016 and has held it in 27 quarters since. The position peaked at $5.38M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Empirical Finance held 48,397 shares of Boston Scientific worth $3.04M as of Q1 2026.
  • Empirical Finance sold 52 Boston Scientific shares in Q1 2026, an estimated $4.16K.
  • Boston Scientific made up 0.14% of Empirical Finance's portfolio in Q1 2026, its #131 holding.
  • Empirical Finance first reported a position in Boston Scientific in Q4 2016 and has held it in 27 quarters since.
  • Empirical Finance's Boston Scientific position peaked at $5.38M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.